Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong · Delayed Price · Currency is HKD 57.50
-1.70 (-2.87%)
Jul 25, 2025, 4:08 PM HKT
Giant Biogene Holding Revenue
In the year 2024, Giant Biogene Holding had annual revenue of 5.54B CNY with 57.17% growth. Giant Biogene Holding had revenue of 3.00B in the half year ending December 31, 2024, with 117.34% growth.
Revenue
5.54B CNY
Revenue Growth
+57.17%
P/S Ratio
10.33
Revenue / Employee
3.15M CNY
Employees
1,758
Market Cap
60.87B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Nongfu Spring | 45.65B |
| MIXUE Group | 26.42B |
| Smoore International Holdings | 12.56B |
| Budweiser Brewing Company APAC | 47.18B |
| WH Group | 201.50B |
| China Resources Beer (Holdings) Company | 41.11B |
| Tsingtao Brewery Company | 34.77B |
| China Mengniu Dairy Company | 94.37B |
Giant Biogene Holding News
- 6 weeks ago - Giant Biogene Bruised In A 'Battle Of The Skincare Belles' - Benzinga